NK-1 receptor antagonists attenuated significantly the growth of HPAF-II tumor xenografts in nude mice, reduced tumor-associated angiogenesis and inhibited Ca2+ mobilization and DNA synthesis in HPAF-II PC cell line [76]. The gene discussed is TACR1; the disease is neoplasm.